DrugDashboards

bromfenac sodium

bromfenac sodium · BROMFENAC SODIUM .805 mg/mL · Solution/ Drops · Ophthalmic · Lupin Pharmaceuticals, Inc.

NDC 68180-0433-02 · 1 BOTTLE, DROPPER in 1 CARTON / 3 mL in 1 BOTTLE, DROPPER · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 22% over the past year, to $12.66 per mL. The brand (Prolensa) runs $115.53 per mL 9.1× more. One of its named manufacturing plants, Lupin Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$12.66per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$61.39per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$14.72per MLweighted avg manufacturer price $5.3514 · Jan 1, 2026116% of what pharmacies pay — higher than 67% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$50.00$100.00Apr 2024Sep 2026$12.66
30 price points · per ML · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2025)

$44,311
561 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for bromfenac sodium (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA206027
TE code
AB
Approval date
Nov 22, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of bromfenac sodium (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.BROMFENAC SODIUM .805 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedBROMFENAC SODIUM .805 mg/mLJul 15, 2026Sep 2, 2026
Apotex Corp.BROMFENAC SODIUM .7 mg/mLJul 15, 2026Sep 2, 2026
Bausch & Lomb Americas Inc.BROMFENAC SODIUM .7 mg/mLJul 15, 2026Sep 2, 2026
Bausch & Lomb IncorporatedBROMFENAC SODIUM .7 mg/mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.BROMFENAC SODIUM .7 mg/mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.BROMFENAC SODIUM .805 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "bromfenac sodium — NDC 68180-0433-02," retrieved September 3, 2026, https://drugdashboards.com/drug/68180043302.

Free to cite with attribution — see how the data is put together.